These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Ophthalmic aspects of erectile dysfunction drugs. Verit A; Oguz H Am J Ophthalmol; 2006 Mar; 141(3):598; author reply 599. PubMed ID: 16490529 [No Abstract] [Full Text] [Related]
24. Lichenoid drug reaction due to sildenafil. Goldman BD Cutis; 2000 May; 65(5):282-3. PubMed ID: 10826087 [TBL] [Abstract][Full Text] [Related]
25. Sildenafil in the treatment of erectile dysfunction. Saldana MJ; Villaran C; Alhalel B N Engl J Med; 1998 Sep; 339(10):700; author reply 701-2. PubMed ID: 9729139 [No Abstract] [Full Text] [Related]
26. [Viagra landing: the dawn of sexual science in cardiology]. Ishikura F J Cardiol; 1999 Sep; 34(3):163-7. PubMed ID: 10500978 [No Abstract] [Full Text] [Related]
27. Sildenafil: medical advance or media event? Rosen RC Lancet; 1998 May; 351(9116):1599-600. PubMed ID: 9620710 [No Abstract] [Full Text] [Related]
29. Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England. Shakir SA; Wilton LV; Boshier A; Layton D; Heeley E BMJ; 2001 Mar; 322(7287):651-2. PubMed ID: 11250850 [No Abstract] [Full Text] [Related]
30. Summary for patients. Sildenafil (Viagra) may help improve control of pulmonary hypertension. Ann Intern Med; 2002 Apr; 136(7):I35. PubMed ID: 11926808 [No Abstract] [Full Text] [Related]
31. A double-blind placebo-controlled evaluation of the acute effects of sildenafil citrate (Viagra) on visual function in subjects with early-stage age-related macular degeneration. Birch DG; Toler SM; Swanson WH; Fish GE; Laties AM Am J Ophthalmol; 2002 May; 133(5):665-72. PubMed ID: 11992864 [TBL] [Abstract][Full Text] [Related]
32. Cyclic GMP phosphodiesterase-5: target of sildenafil. Corbin JD; Francis SH J Biol Chem; 1999 May; 274(20):13729-32. PubMed ID: 10318772 [No Abstract] [Full Text] [Related]
33. Erectile dysfunction, sildenafil and cardiovascular risk. Langton PE Med J Aust; 2000 Oct; 173(8):446. PubMed ID: 11090041 [No Abstract] [Full Text] [Related]
34. Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. Cheitlin MD; Hutter AM; Brindis RG; Ganz P; Kaul S; Russell RO; Zusman RM Circulation; 1999 Jan 5-12; 99(1):168-77. PubMed ID: 9884398 [No Abstract] [Full Text] [Related]
35. Cardiovascular events in users of sildenafil. Paper does not provide any reassurance. Dunn N BMJ; 2001 Jul; 323(7303):50-1. PubMed ID: 11464831 [No Abstract] [Full Text] [Related]
36. Effects of phosphodiesterase type 5 inhibitor sildenafil on retinal function in isolated superfused retina. Lüke M; Lüke C; Hescheler J; Schneider T; Sickel W J Ocul Pharmacol Ther; 2005 Aug; 21(4):305-14. PubMed ID: 16117694 [TBL] [Abstract][Full Text] [Related]
37. [Is it safe for cardiological patients to take sildenafil (viagra) to correct erectile dysfunction? (lectures)]. Metelitsa VI Ter Arkh; 2000; 72(6):67-9. PubMed ID: 10900657 [No Abstract] [Full Text] [Related]